drugset / Trial / NCT05459402

Divided or Single Exposure (DOSE) Study

NCT05459402

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate whether once versus twice daily dosing of methadone will be an effective method for managing comorbid pain and opioid use disorder.

Timeline

Start
2023-02-21
Primary completion
2027-06-01
Completion
2028-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methadone Other / unclassified 50 %
Comparator Methadone Other / unclassified 100 %